# Isosceles Pharmaceuticals, Inc. — Form C (Regulation Crowdfunding)

Isosceles Pharmaceuticals, Inc. of Wilmington, NC filed a Form C (Regulation Crowdfunding) with the SEC on 2022-10-03. Target raise $20K, up to $5.0M. Offered through Equifund Crowd Funding Portal Inc..

## Offering

- Filed: 2022-10-03
- Form: C
- Accession: 0001213900-22-061146
- Target amount: $20K
- Maximum amount: $5.0M
- Security type: Common Stock
- Securities offered: 9,756
- Price: $2.0500
- Deadline: 2023-10-02
- Funding portal / intermediary: Equifund Crowd Funding Portal Inc.
- Intermediary file number: 007-00115
- Intermediary CRD: 288900

## Issuer

- CIK: 0001949237
- Website: www.isoscelespharma.com
- Legal status: Corporation
- Organized in: NV
- Incorporated: 2019-04-12
- Address: 1213 Culbreth Dr. Suite 359, Wilmington, NC, 28405
- Employees: 10

## Financials (as filed)

- Total assets (most recent): $213K
- Cash (most recent): $213K
- Net income (most recent): $880K
- Net income (prior): $892K
- Long-term debt: $120K

## People (1)

| Name | Role | Location |
| --- | --- | --- |
| Brett Lanier | President | Wilmington, NC |

## More

- [CIK 1949237 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1949237&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formc/0001213900-22-061146.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.